Literature DB >> 26190263

The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential.

Stephen H K Wong1, David L Goode2, Masayuki Iwasaki1, Michael C Wei1, Hsu-Ping Kuo1, Li Zhu1, Dominik Schneidawind3, Jesus Duque-Afonso1, Ziming Weng4, Michael L Cleary5.   

Abstract

The genetic programs that maintain leukemia stem cell (LSC) self-renewal and oncogenic potential have been well defined; however, the comprehensive epigenetic landscape that sustains LSC cellular identity and functionality is less well established. We report that LSCs in MLL-associated leukemia reside in an epigenetic state of relative genome-wide high-level H3K4me3 and low-level H3K79me2. LSC differentiation is associated with reversal of these broad epigenetic profiles, with concomitant downregulation of crucial MLL target genes and the LSC maintenance transcriptional program that is driven by the loss of H3K4me3, but not H3K79me2. The H3K4-specific demethylase KDM5B negatively regulates leukemogenesis in murine and human MLL-rearranged AML cells, demonstrating a crucial role for the H3K4 global methylome in determining LSC fate.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26190263      PMCID: PMC4536132          DOI: 10.1016/j.ccell.2015.06.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  48 in total

1.  RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity.

Authors:  Sonia Cellot; Kristin J Hope; Jalila Chagraoui; Martin Sauvageau; Éric Deneault; Tara MacRae; Nadine Mayotte; Brian T Wilhelm; Josette R Landry; Stephen B Ting; Jana Krosl; Keith Humphries; Alexander Thompson; Guy Sauvageau
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

2.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

3.  PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.

Authors:  Steven Catchpole; Bradley Spencer-Dene; Debbie Hall; Samantha Santangelo; Ian Rosewell; Mounia Guenatri; Richard Beatson; Angelo G Scibetta; Joy M Burchell; Joyce Taylor-Papadimitriou
Journal:  Int J Oncol       Date:  2011-02-28       Impact factor: 5.650

4.  Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.

Authors:  Carsten Müller-Tidow; Hans-Ulrich Klein; Antje Hascher; Fabienne Isken; Lara Tickenbrock; Nils Thoennissen; Shuchi Agrawal-Singh; Petra Tschanter; Christine Disselhoff; Yipeng Wang; Anke Becker; Christian Thiede; Gerhard Ehninger; Udo zur Stadt; Steffen Koschmieder; Matthias Seidl; Frank U Müller; Wilhelm Schmitz; Peter Schlenke; Michael McClelland; Wolfgang E Berdel; Martin Dugas; Hubert Serve
Journal:  Blood       Date:  2010-05-24       Impact factor: 22.113

5.  AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.

Authors:  Aniruddha J Deshpande; Anagha Deshpande; Amit U Sinha; Liying Chen; Jenny Chang; Ali Cihan; Maurizio Fazio; Chun-Wei Chen; Nan Zhu; Richard Koche; Liuda Dzhekieva; Gloria Ibáñez; Stuart Dias; Deepti Banka; Andrei Krivtsov; Minkui Luo; Robert G Roeder; James E Bradner; Kathrin M Bernt; Scott A Armstrong
Journal:  Cancer Cell       Date:  2014-11-20       Impact factor: 31.743

Review 6.  Chromatin modifiers and remodellers: regulators of cellular differentiation.

Authors:  Taiping Chen; Sharon Y R Dent
Journal:  Nat Rev Genet       Date:  2013-12-24       Impact factor: 53.242

7.  Extended self-renewal and accelerated reprogramming in the absence of Kdm5b.

Authors:  Benjamin L Kidder; Gangqing Hu; Zu-Xi Yu; Chengyu Liu; Keji Zhao
Journal:  Mol Cell Biol       Date:  2013-10-07       Impact factor: 4.272

8.  Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal.

Authors:  Deqiang Sun; Min Luo; Mira Jeong; Benjamin Rodriguez; Zheng Xia; Rebecca Hannah; Hui Wang; Thuc Le; Kym F Faull; Rui Chen; Hongcang Gu; Christoph Bock; Alexander Meissner; Berthold Göttgens; Gretchen J Darlington; Wei Li; Margaret A Goodell
Journal:  Cell Stem Cell       Date:  2014-05-01       Impact factor: 24.633

9.  seqMINER: an integrated ChIP-seq data interpretation platform.

Authors:  Tao Ye; Arnaud R Krebs; Mohamed-Amin Choukrallah; Celine Keime; Frederic Plewniak; Irwin Davidson; Laszlo Tora
Journal:  Nucleic Acids Res       Date:  2010-12-21       Impact factor: 16.971

10.  Immunogenetics. Chromatin state dynamics during blood formation.

Authors:  David Lara-Astiaso; Assaf Weiner; Erika Lorenzo-Vivas; Irina Zaretsky; Diego Adhemar Jaitin; Eyal David; Hadas Keren-Shaul; Alexander Mildner; Deborah Winter; Steffen Jung; Nir Friedman; Ido Amit
Journal:  Science       Date:  2014-08-07       Impact factor: 47.728

View more
  51 in total

1.  SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically.

Authors:  Tianming Li; Qidi Zheng; Jiahui An; Mengying Wu; Haiyan Li; Xin Gui; Hu Pu; Dongdong Lu
Journal:  Mol Ther       Date:  2015-11-19       Impact factor: 11.454

Review 2.  Biology and relevance of human acute myeloid leukemia stem cells.

Authors:  Daniel Thomas; Ravindra Majeti
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

Review 3.  JARID1 Histone Demethylases: Emerging Targets in Cancer.

Authors:  Kayla M Harmeyer; Nicole D Facompre; Meenhard Herlyn; Devraj Basu
Journal:  Trends Cancer       Date:  2017-09-12

4.  CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia.

Authors:  Jesús Duque-Afonso; Chiou-Hong Lin; Kyuho Han; David W Morgens; Edwin E Jeng; Ziming Weng; Johan Jeong; Stephen Hon Kit Wong; Li Zhu; Michael C Wei; Hee-Don Chae; Martin Schrappe; Gunnar Cario; Justus Duyster; Xiangshu Xiao; Kathleen M Sakamoto; Michael C Bassik; Michael L Cleary
Journal:  Cancer Res       Date:  2018-09-27       Impact factor: 12.701

5.  Global chromatin architecture defines functional cancer hierarchies.

Authors:  Marco Gallo; Peter B Dirks
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

Review 6.  KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer.

Authors:  Besa Xhabija; Benjamin L Kidder
Journal:  Semin Cancer Biol       Date:  2018-11-16       Impact factor: 15.707

7.  E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.

Authors:  Jesús Duque-Afonso; Chiou-Hong Lin; Kyuho Han; Michael C Wei; Jue Feng; Jason H Kurzer; Corina Schneidawind; Stephen Hon-Kit Wong; Michael C Bassik; Michael L Cleary
Journal:  Cancer Res       Date:  2016-10-07       Impact factor: 12.701

8.  Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.

Authors:  John R Horton; Amanda Engstrom; Elizabeth L Zoeller; Xu Liu; John R Shanks; Xing Zhang; Margaret A Johns; Paula M Vertino; Haian Fu; Xiaodong Cheng
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

Review 9.  Therapeutic targeting potential of chromatin-associated proteins in MLL-rearranged acute leukemia.

Authors:  Xin Xu; Björn Schneider
Journal:  Cell Oncol (Dordr)       Date:  2018-11-16       Impact factor: 6.730

10.  Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.

Authors:  Lin Zha; Qiang Cao; Xin Cui; Fenfen Li; Houjie Liang; Bingzhong Xue; Hang Shi
Journal:  Med Oncol       Date:  2016-01-27       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.